Most cited papers from Medical Radiological Research Center
What are the most cited papers from Medical Radiological Research Center?
The most cited paper from Medical Radiological Research Center is "Duration of Androgen Suppression in the Treatment of Prostate Cancer" (M. Bolla, Theodorus M. de Reijke, Geertjan van Tienhoven et al., 2009), with 977 citations. Next come "Necrosis: a specific form of programmed cell death?" (721) and "Risk of Thyroid Cancer After Exposure to 131 I in Childhood" (594).
Showing 50 of 59 papers. Every paper with more than 82 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Duration of Androgen Suppression in the Treatment of Prostate Cancer M. Bolla, Theodorus M. de Reijke, Geertjan van Tienhoven et al. · New England Journal of Medicine | 10 Jun 2009 | 977 |
| 2 | Necrosis: a specific form of programmed cell death? Sergey Proskuryakov, Anatoli G Konoplyannikov, Vladimir L. Gabai · Experimental Cell Research | Feb 2003 | 721 |
| 3 | Risk of Thyroid Cancer After Exposure to 131 I in Childhood Elisabeth Cardis et al. · JNCI Journal of the National Cancer Institute | 17 May 2005 | 594 |
| 4 | Induction of oxyradicals by arsenic: Implication for mechanism of genotoxicity Su X. Liu, Mohammad Athar, István Lippai et al. · Proceedings of the National Academy of Sciences | 6 Feb 2001 | 539 |
| 5 | Hsp70 Prevents Activation of Stress Kinases Vladimir L. Gabai, Anatoli B. Meriin, Dick D. Mosser et al. · Journal of Biological Chemistry | Jul 1997 | 511 |
| 6 | Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial Matthew R. Smith et al. · The Lancet Oncology | 10 Feb 2019 | 412 |
| 7 | BRAF mutations are associated with some histological types of papillary thyroid carcinoma Vítor Trovisco, Inês Vieira de Castro, Paula Soares et al. · The Journal of Pathology | 19 Jan 2004 | 368 |
| 8 | Systematic Review and Meta-analysis of Circulatory Disease from Exposure to Low-Level Ionizing Radiation and Estimates of Potential Population Mortality Risks Mark P. Little et al. · Environmental Health Perspectives | 22 Jun 2012 | 368 |
| 9 | Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer Sunil R. Hingorani, William Proctor Harris, Joseph Thaddeus Beck et al. · Clinical Cancer Research | 26 Jan 2016 | 330 |
| 10 | Proteasome Inhibitors Activate Stress Kinases and Induce Hsp72 Anatoli B. Meriin, Vladimir L. Gabai, Julia A. Yaglom et al. · Journal of Biological Chemistry | Mar 1998 | 302 |
| 11 | Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial Ian F. Tannock et al. · The Lancet Oncology | 3 Jun 2013 | 289 |
| 12 | Zinc in the human prostate gland: Normal, hyperplastic and cancerous V. Ye. Zaichick, Tatiana V. Sviridova, Sofia Zaichick · International Urology and Nephrology | Sep 1997 | 265 |
| 13 | Cancer consequences of the Chernobyl accident: 20 years on Elisabeth Cardis et al. · Journal of Radiological Protection | 24 Apr 2006 | 246 |
| 14 | Phase 3 Trial of Selpercatinib in Advanced RET -Mutant Medullary Thyroid Cancer Julien Hadoux et al. · New England Journal of Medicine | 21 Oct 2023 | 207 |
| 15 | Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials Jeremy G. Franklin et al. · Annals of Oncology | 19 Sep 2006 | 189 |
| 16 | Hsp70–Bag3 Interactions Regulate Cancer-Related Signaling Networks Teresa A. Colvin, Vladimir L. Gabai, Jianlin Gong et al. · Cancer Research | 4 Jul 2014 | 187 |
| 17 | Accumulation of rare earth elements in human bone within the lifespan Sofia Zaichick, Vladimir Zaichick, В. К. Карандашев et al. · Metallomics | 21 Dec 2010 | 186 |
| 18 | THE RISK OF RADIATION-INDUCED CEREBROVASCULAR DISEASE IN CHERNOBYL EMERGENCY WORKERS V.K. Ivanov, М.А. Maksioutov, Sergey Yu. Chekin et al. · Health Physics | 3 Feb 2006 | 183 |
| 19 | BRAFMutations Are Not a Major Event in Post-Chernobyl Childhood Thyroid Carcinomas Jorge Pereira Lima, Vítor Trovisco, Paula Soares et al. · The Journal of Clinical Endocrinology & Metabolism | Sep 2004 | 182 |
| 20 | Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside Xuhui Bao, Yongjun Liang, Hanman Chang et al. · Signal Transduction and Targeted Therapy | 7 Jan 2024 | 179 |
| 21 | The Chernobyl Accident and its Consequences Vladimir Saenko, V.K. Ivanov, Anatoli F. Tsyb et al. · Clinical Oncology | 23 Feb 2011 | 169 |
| 22 | Ionising radiation and cardiovascular disease: systematic review and meta-analysis Mark P. Little, Tamara V. Azizova, David Bonner Richardson et al. · BMJ | 8 Mar 2023 | 160 |
| 23 | Cell Death and Survival Assays Alexander E. Kabakov, Vladimir L. Gabai · Methods in molecular biology | 25 Nov 2017 | 159 |
| 24 | Hsp72-Mediated Suppression of c-Jun N-Terminal Kinase Is Implicated in Development of Tolerance to Caspase-Independent Cell Death Vladimir L. Gabai, Julia A. Yaglom, Vladimir Volloch et al. · Molecular and Cellular Biology | Sep 2000 | 158 |
| 25 | Extrapineal Melatonin: Location and Role within Diffuse Neuroendocrine System Igor Moiseevich Kvetnoy · The Histochemical Journal | 1999 | 156 |
| 26 | Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing Alexander E. Kabakov, Anna O. Yakimova · Cancers | 4 Mar 2021 | 153 |
| 27 | Adverse events, side effects and complications in mesenchymal stromal cell-based therapies Denis Baranovskii, Ilya Klabukov, Nadezhda V. Arguchinskaya et al. · Stem Cell Investigation | Nov 2022 | 147 |
| 28 | Iodine deficiency, radiation dose, and the risk of thyroid cancer among children and adolescents in the Bryansk region of Russia following the Chernobyl power station accident V.V. Shakhtarin, А. Ф. Цыб, Valeriy F. STEPANENKO et al. · International Journal of Epidemiology | Aug 2003 | 147 |
| 29 | Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness E. D. Williams, A Abrosimov, Bogdanova Ti et al. · British Journal of Cancer | 11 May 2004 | 141 |
| 30 | Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL Fritz C. Offner, Olga S. Samoilova, Evgenii A. Osmanov et al. · Blood | 31 Jul 2015 | 138 |
| 31 | Medical elementology as a new scientific discipline Vladimir Zaichick · Journal of Radioanalytical and Nuclear Chemistry | Aug 2006 | 136 |
| 32 | Induction of oxyradicals by arsenic: Implication for mechanism of genotoxicity Song-Yao Liu · Proceedings of the National Academy of Sciences | 6 Feb 2001 | 133 |
| 33 | Trace elements and thyroid cancer Vladimir Zaichick, Anatoli F. Tsyb, Boris M. Vtyurin · The Analyst | 1995 | 132 |
| 34 | Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents Vladimir L. Gabai, K. R. Budagova, Michael Y. Sherman · Oncogene | 21 Feb 2005 | 130 |
| 35 | Neuroendocrine differentiation in human gastric carcinoma. Helge Lyder Waldum, Steinar Aase, И. М. Кветной et al. · PubMed | Aug 1998 | 124 |
| 36 | Modulation of in Vivo HSP70 Chaperone Activity by Hip and Bag-1 Ellen A. A. Nollen, Alexander E. Kabakov, Jeanette F. Brunsting et al. · Journal of Biological Chemistry | Feb 2001 | 121 |
| 37 | Risk of Thyroid Cancer in the Bryansk Oblast of the Russian Federation after the Chernobyl Power Station Accident S. Scott Davis, Valeriy F. STEPANENKO, Nikolai Rivkind et al. · Radiation Research | Sep 2004 | 120 |
| 38 | Risk of Hematological Malignancies among Chernobyl Liquidators Ausrele Kesminiene et al. · Radiation Research | 13 Nov 2008 | 119 |
| 39 | Statistical Mechanics for a Class of Quantum Statistics SERGEI B. ISAKOV · Physical Review Letters | 17 Oct 1994 | 118 |
| 40 | The second international intercomparison on EPR tooth dosimetry A. Wieser et al. · Radiation Measurements | Dec 2000 | 112 |
| 41 | Impedance Spectroscopy as a Tool for Monitoring Performance in 3D Models of Epithelial Tissues T. N. Gerasimenko, Sergey V. Nikulin, Г. С. Захарова et al. · Frontiers in Bioengineering and Biotechnology | 23 Jan 2020 | 111 |
| 42 | Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors Timothy Anthony Yap, Aditya Bardia, Michael Dvorkin et al. · JAMA Oncology | 17 Nov 2022 | 109 |
| 43 | Kidney Injury Molecule 1 (KIM-1): a Multifunctional Glycoprotein and Biological Marker (Review) Tatyana A. Karmakova, Natalia S. Sergeeva, K. Yu. Kanukoev et al. · Современные технологии в медицине | Jun 2021 | 109 |
| 44 | Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy Alexander E. Kabakov, Anna O. Yakimova, Olga N. Matchuk · Cells | 6 Apr 2020 | 109 |
| 45 | Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses Paul Mitchell, N. M. Thatcher, Mark A. Socinski et al. · Annals of Oncology | 27 Feb 2015 | 109 |
| 46 | Suppression of Stress Kinase JNK Is Involved in HSP72-mediated Protection of Myogenic Cells from Transient Energy Deprivation Vladimir L. Gabai, Anatoli B. Meriin, Julia A. Yaglom et al. · Journal of Biological Chemistry | Dec 2000 | 104 |
| 47 | Zinc concentration in human prostatic fluid: Normal, chronic prostatitis, adenoma and cancer Vladimir Zaichick, Tatiana V. Sviridova, Sofia Zaichick · International Urology and Nephrology | Sep 1996 | 94 |
| 48 | Risk of Thyroid Cancer among Chernobyl Liquidators Ausrele Kesminiene, Anne-Sophie Evrard, V.K. Ivanov et al. · Radiation Research | 21 Sep 2012 | 93 |
| 49 | A search for losses of chemical elements during freeze-drying of biological materials Vladimir Zaichick, Sofia Zaichick · Journal of Radioanalytical and Nuclear Chemistry | Apr 1997 | 92 |
| 50 | Necrosis Is an Active and Controlled Form of Programmed Cell Death S. Ya. Proskuryakov, Vladimir L. Gabai, Anatoly Konoplyannikov · Biochemistry (Moscow) | Apr 2002 | 92 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.